Erlocip 100 mg Tablets
3200 INR/Bottle
Product Details:
- Indication Non-small cell lung cancer, Pancreatic cancer
- Dosage Form Tablet
- Salt Composition Erlotinib (100 mg)
- Enzyme Types Other
- Feature Oral targeted therapy, EGFR Tyrosine Kinase Inhibitor
- Ingredients Erlotinib hydrochloride and excipients
- Application Oncology use, Anticancer
- Click to View more
X
Erlocip 100 mg Tablets Price And Quantity
- 1 Bottle
- 3200 INR/Bottle
- 100 mg
- Oral
- Blister pack
- Erlocip
- 30 Tablets per box
- Cipla
- Prescription only
- As printed on pack
Erlocip 100 mg Tablets Product Specifications
- Tablet
- Slight Smell
- Erlotinib hydrochloride and excipients
- 1 Years
- Erlotinib (100 mg)
- Dry place
- Oncology use, Anticancer
- Non-small cell lung cancer, Pancreatic cancer
- Other
- Oral targeted therapy, EGFR Tyrosine Kinase Inhibitor
- White to off-white tablet
- 100 mg
- Oral
- Blister pack
- Erlocip
- 30 Tablets per box
- Cipla
- Prescription only
- As printed on pack
Product Description
Technical Specification
- Minimum Order Quantity : 1 Bottle
- Form : Tablet
- Packaging Size : 30
- Prescription/Non prescription : Prescription
- Treatment : Non-small cell lung cancer Pancreatic cancer
- Manufacturer : cipla
- Composition : Erlotinib
- Brand : Erlocip
Oncology Targeted Therapy
Erlocip 100 mg Tablets deliver a targeted therapeutic approach for oncology patients, specifically in cases of non-small cell lung cancer and pancreatic cancer. This medication inhibits the activity of EGFR tyrosine kinase, directly impacting cancer cell growth.
Convenient Oral Administration
These tablets are designed for oral use, offering a non-invasive route of administration that can be easily integrated into daily routines. The 100 mg strength ensures precise dosing as prescribed by your oncologist.
Reliable Cipla Quality
Erlocip is manufactured and marketed by Cipla, a reputable pharmaceutical company renowned for its quality and reliability. Each blister pack ensures product integrity, with all information, including batch number and packaging details, printed clearly.
FAQ's of Erlocip 100 mg Tablets:
Q: How should Erlocip 100 mg Tablets be taken?
A: Erlocip 100 mg Tablets should be taken exactly as prescribed by your doctor, usually once daily, on an empty stomach at least one hour before or two hours after eating. Follow your physician's guidance for optimal results.Q: What is Erlocip 100 mg Tablets used for?
A: Erlocip 100 mg Tablets are indicated for the treatment of non-small cell lung cancer and pancreatic cancer. It acts as a targeted therapy by inhibiting the growth signals of cancer cells.Q: When should I seek medical advice while taking Erlocip?
A: Contact your healthcare provider if you experience any unusual symptoms, persistent side effects, or signs of an allergic reaction. Regular monitoring by your doctor is important during treatment.Q: Where should I store Erlocip 100 mg Tablets?
A: Store the tablets in a cool, dry place, away from direct sunlight and moisture. Ensure the medication is kept out of reach of children and pets. Use within the designated shelf life of one year from the batch date.Q: What process does Erlocip follow to target cancer?
A: Erlocip acts as an EGFR tyrosine kinase inhibitor, blocking signals that promote tumor cell division and proliferation in specific cancers, thus helping to slow or stop the spread of cancer cells.Q: What is the benefit of using Erlocip 100 mg Tablets in cancer therapy?
A: Erlocip provides targeted action against certain cancers, which may result in better treatment outcomes and potentially fewer side effects compared to conventional chemotherapy, as it specifically inhibits cancer cell growth mechanisms.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicine' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
